What You Need to Know About Genomics

June 6, 2019
Kristie L. Kahl
Kristie L. Kahl

Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.

In this week’s episode, we spoke with a patient and his doctor about genomic testing and how it can change treatment outcomes for patients with cancer.

Cancer is no longer the once thought “one-size-fits-all” approach when it comes to treatment, especially because genomic testing plays such a crucial role for certain patients.

This week, we spoke with Bryce, who was diagnosed with prostate cancer in 2014 and whose cancer journey was changed once he discovered what genomic testing could do for his treatment options. In addition, Dr. Marcia Brose, from the University of Pennsylvania, weighs in on what patients should know about genomic cancer testing.

To learn more, visit testyourcancer.com.

Related Content:

PodcastsProstate Cancer
PSMA-Targeted Radiation Drug for Prostate Cancer Subset Meets Study Goal
How Circulating Tumor Cell Count Can Inform Prostate Cancer Treatment
Circulating Tumor Cells May Predict Prostate Cancer Survival